Fractional flow reserve‐guided paclitaxel‐coated balloon treatment for de novo coronary lesions

@article{Shin2016FractionalFR,
  title={Fractional flow reserve‐guided paclitaxel‐coated balloon treatment for de novo coronary lesions},
  author={E. Shin and S. Ann and Gillian Balbir Singh and K. Lim and F. Kleber and B. Koo},
  journal={Catheterization and Cardiovascular Interventions},
  year={2016},
  volume={88}
}
  • E. Shin, S. Ann, +3 authors B. Koo
  • Published 2016
  • Medicine
  • Catheterization and Cardiovascular Interventions
To assess the safety and efficacy of fractional flow reserve (FFR) guided paclitaxel‐coated balloon (PCB) treatment for de novo coronary artery lesions. Background: There is limited data on PCB treatment for de novo lesions especially of major epicardial coronary arteries. 
View on Wiley
ncbi.nlm.nih.gov
24 Citations
Background Citations
5
Methods Citations
4

Paper Mentions

Observational Patient Registry Clinical Trial
Angioplasty With Paclitaxel-coated Balloon Only Strategy for Coronary de Novo Lesions
Drug-coating balloon (DCB) is a new interventional device for treatment of obstructive coronary artery disease (CAD). There is limited data on the long term efficacy and safety of… Expand
ConditionsCoronary Disease
InterventionDevice
Beijing Hospital
August 2019 - July 2023

24 Citations

Citation Type

Citation Type

Provisional drug-coated balloon treatment guided by physiology on de novo coronary lesion.
  • PDF
Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions
  • 1
Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty
  • A. Her, E. Shin, +4 authors B. Koo
  • Medicine
  • The International Journal of Cardiovascular Imaging
  • 2018
  • 7
Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review
  • 12
  • PDF
Plaque modification and stabilization after paclitaxel-coated balloon treatment for de novo coronary lesions
  • 1
Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography
  • 19
  • PDF
Impact of Dissection after Drug-Coated Balloon Treatment of De Novo Coronary Lesions: Angiographic and Clinical Outcomes
  • PDF
Serial Morphological and Functional Assessment of the Paclitaxel-coated Balloon for de Novo Lesions.
  • 8
Survival After Coronary Revascularization With Paclitaxel-Coated Balloons.
  • 19
Drug‐Coated Balloon Versus Drug‐Eluting Stent in Primary Percutaneous Coronary Intervention: A Feasibility Study☆,☆☆
  • 14
...
1
2
3
...

References

SHOWING 1-10 OF 23 REFERENCES
One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.
  • 152
  • PDF
Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial.
  • R. Waksman, A. Serra, +5 authors A. Rodríguez
  • Medicine
  • EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
  • 2013
  • 72
Drug‐coated balloon treatment of coronary artery disease: A position paper of the Italian Society of Interventional Cardiology
  • B. Cortese, S. Berti, +6 authors G. Sgueglia
  • Medicine
  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2014
  • 55
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?
  • M. Unverdorben, F. Kleber, +10 authors B. Scheller
  • Medicine
  • EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
  • 2013
  • 64
Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group
  • 109
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
  • 2,568
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
  • 273
  • PDF
A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION
  • 1,036
  • PDF
Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty.
  • 139
  • Highly Influential
  • PDF
Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis
  • 445
  • PDF
...
1
2
3
...